In line with Europe’s Cancer Mission and Beating Cancer Plan, canSERV promotes the development of concrete solutions for cancer by providing a comprehensive set of world-class
oncology technologies and state of the art training to cancer scientists.
canSERV Enables Researchers to Cover the Entire Range of the Oncology Developmental Pipeline
Following the success of the previous Challenge-Call on “Advancing Personalised Oncology”, canSERV now invites applications covering the entire range of the oncology developmental
pipeline; supporting discoveries in fundamental research to translational science and personalised oncology.
canSERV welcomes excellent research applications addressing at least one of the four strategic goals of the Cancer Mission:
- Understanding of Cancer
- Prevention and Early Detection
- Diagnosis and treatment
- Quality of life for patients and their families
Researchers from academia, industry and SMEs may apply for several services including: i) disease models, ii) cutting-edge imaging and structural biology technologies, iii)
biomarker research and development, iv) new therapeutic solutions, v) complex clinical trial design and support, vi) personalised oncology implementation pipelines and recommendations and vii) regulatory support and tools to analyse the socioeconomic dimension
of research activities.
Launch of the call is today,
12 October 2023.
Submission deadline is
4 January 2024, 2pm CET.
The applications will be reviewed by an international, independent review panel!
The tentative budget for this first call is 1.0 Mio. EURO. For more information and the call text, please visit our CanSERV project website: www.canSERV.eu/Calls
Further information:
canSERV website: www.canserv.eu
Twitter: @canSERV_EU
LinkedIn: canSERV
Project coordination, BBMRI-ERIC:
Prof. Jens K. Habermann, Director General
Judit Balogh, Senior Project Manager
canSERV
Call
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101058620.
The information and views set out in this press release are those of the author(s) and do not necessarily reflect the official opinion of the European Union.
Neither the European Union institutions and bodies nor any person acting on their behalf may be held responsible for the use which may be made of the information contained therein.
ARTTIC Innovation GmbH has been advising research and innovation projects for more than 33 years. As project management and communication partner, we make
sure that our projects run successfully and that project results and events are disseminated in the best possible way. ARTTIC is a subsidiary of the PNO Group, one of the largest consultancies for publicly funded projects in research and development. For more
information, please visit www.arttic-innovation.de.
We take your privacy seriously. Click
here to read our privacy policy. If you no longer wish to receive emails from us, please click below.
You can unsubscribe
here.
